How does GBM AGILE work?, page-74

Just announced.
Another exciting #GBMAGILE update: We are delighted to share that paxalisib and VAL-083 are now active in Switzerland! University Hospital Zurich
Site and regional PI: Dr. Michael Weller
Additional trial locations in Europe to follow.

Exciting to see more paxalisib data being created for release next year, and I look forward to Dr. Michael Weller maybe testing patients with the above combination in the future.

................................................................................................................................
Interesting video on GBM and GBM AGILE.
https://www.nfcr.org/blog/nfcr-speaks-with-nbc-washington-about-late-colleague-2022/

Regards.